| Date |
Title |
Publication |
| 11/02/1011/02/10 |
Exit Strategies, presented at the New Jersey Technology Council CFO Thought Leadership Series
|
Speech |
| 10/21/1010/21/10 |
Corporate VCs – Any Side Effects?, presented at the youngStartUp 2010 Life Sciences and Healthcare Venture Summit
|
Speech |
| 10/01/1010/01/10 |
Successful Leadership Strategies During This Time of Regulatory and Economic Change, presented at the NJTC Executive Leadership Summit
|
Speech |
| 04/21/1004/21/10 |
Choosing the Ideal Structure for your Business Entity and Venture Capital Investment in 2010, presented at the Columbia University Entrepreneurial Program
View Presentation
|
Speech |
| 04/20/1004/20/10 |
Venture Outlook: Challenges and Opportunities, presented at the 2010 Boston Biotech & Healthcare Venture Summit
View Presentation
|
Speech |
| 10/27/0910/27/09 |
Funding Healthcare and IT Media, presented at the 2009 New York Life Sciences & Healthcare Venture Summit
View Presentation
|
Speech |
| 10/20/0910/20/09 |
Executing and Documenting the Deal, presented at ACI's Financing Solutions & Strategies for Life Sciences Post-Conference Workshop
View Presentation
|
Speech |
| 03/01/07March 2007 |
New SEC Executive Compensation Rules Seek to Provide Clear Picture for Investors, New Jersey TechNews
|
Article |
| 12/08/0612/08/06 |
Final SEC Executive Compensation Disclosure Requirements, presented to the New Jersey Technology Council
|
Speech |
| 10/06/0610/06/06 |
Biotechnology Mergers and Acquisitions, presented at Law Seminars International
View Presentation
|
Speech |
| 09/20/0509/20/05 |
Sarbanes-Oxley Compliance: Where are we now?, presented to the NJTC
View Presentation
|
Speech |
| 09/02/02September 2002 |
Sarbanes-Oxley Act: Politics or Reform? Statute's Effects Are Not as Profound as Legislators Would Have Us Believe (co-author), New Jersey Law Journal
|
Article |
